Condition: Hiv · Drug Use · Sponsor: Yale University
This study seeks to develop an RS-ART implementation strategy by utilizing the Delphi method and interviewing experts and PWID regarding their experiences with ART. This strategy will then be pilot tested in a randomized controlled trial (Aim 3). The research will not impact the type of medication and dose prescribed, but rather, how soon providers are able to prescribe ART after diagnosis. The focus of this registration is Aim 3.
This description comes directly from the study's public registry record.
David Oliveros Gómez, MPH · 202-805-8118 · david.oliveros@yale.edu
Daniel J Bromberg, MS · 781-588-3019 · dan.bromberg@yale.edu
Always discuss trial participation with your own doctor first.
| Kajang Prison | Kajang, Malaysia | Recruiting |
| Centre of Excellence for Research in AIDS (CERiA) - University of Malaya | Kuala Lumpur, Malaysia | Active Not Recruiting |
| Primary Healthcare Centers | Kuala Lumpur, Malaysia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06541028